Woven polydioxanone biodegradable stents: A new treatment option for benign and malignant oesophageal strictures

S. M. Stivaros; L. R. Williams; C. Senger; L. Wilbraham; Hans Ulrich Laasch

doi:10.1007/s00330-009-1662-5

Woven polydioxanone biodegradable stents: A new treatment option for benign and malignant oesophageal strictures

S. M. Stivaros, L. R. Williams, C. Senger, L. Wilbraham, Hans Ulrich Laasch

Research output: Contribution to journal › Article › peer-review

Abstract

Background: We present our initial experience with a new biodegradable (BD) esophageal stent in two patients, one for a therapy-resistant benign esophageal stricture, and the other as a temporary measure during curative radiotherapy for oesophageal carcinoma. Methods: The BD stents need to be loaded into a conventional pull-back delivery system but are then placed in a standard fashion. Pre-dilatation should be avoided to reduce the risk of migration, however if migration occurs the stents can be left to dissolve in the stomach. The stents are radiolucent but easily identified on CT with minimal artefact and thus might even aid with radiotherapy planning. Results: BD stents offer an exciting new strategy for therapy-resistant benign strictures as well as a supportive measure for oesophageal cancer undergoing non-surgical treatment. © 2009 European Society of Radiology.

Original language	English
Pages (from-to)	1069-1072
Number of pages	3
Journal	European Radiology
Volume	20
Issue number	5
DOIs	https://doi.org/10.1007/s00330-009-1662-5
Publication status	Published - 2010

Keywords

Biodegradable
Dilatation
Endoscopy
Oesophageal neoplasms
Oesophageal stenosis
Stents

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00330-009-1662-5

Cite this

@article{5fcc7622a7124eeebb370f6036f7c34d,

title = "Woven polydioxanone biodegradable stents: A new treatment option for benign and malignant oesophageal strictures",

abstract = "Background: We present our initial experience with a new biodegradable (BD) esophageal stent in two patients, one for a therapy-resistant benign esophageal stricture, and the other as a temporary measure during curative radiotherapy for oesophageal carcinoma. Methods: The BD stents need to be loaded into a conventional pull-back delivery system but are then placed in a standard fashion. Pre-dilatation should be avoided to reduce the risk of migration, however if migration occurs the stents can be left to dissolve in the stomach. The stents are radiolucent but easily identified on CT with minimal artefact and thus might even aid with radiotherapy planning. Results: BD stents offer an exciting new strategy for therapy-resistant benign strictures as well as a supportive measure for oesophageal cancer undergoing non-surgical treatment. {\textcopyright} 2009 European Society of Radiology.",

keywords = "Biodegradable, Dilatation, Endoscopy, Oesophageal neoplasms, Oesophageal stenosis, Stents",

author = "Stivaros, {S. M.} and Williams, {L. R.} and C. Senger and L. Wilbraham and Laasch, {Hans Ulrich}",

year = "2010",

doi = "10.1007/s00330-009-1662-5",

language = "English",

volume = "20",

pages = "1069--1072",

journal = "European Radiology",

issn = "0938-7994",

publisher = "Springer Nature",

number = "5",

}

TY - JOUR

T1 - Woven polydioxanone biodegradable stents: A new treatment option for benign and malignant oesophageal strictures

AU - Stivaros, S. M.

AU - Williams, L. R.

AU - Senger, C.

AU - Wilbraham, L.

AU - Laasch, Hans Ulrich

PY - 2010

Y1 - 2010

N2 - Background: We present our initial experience with a new biodegradable (BD) esophageal stent in two patients, one for a therapy-resistant benign esophageal stricture, and the other as a temporary measure during curative radiotherapy for oesophageal carcinoma. Methods: The BD stents need to be loaded into a conventional pull-back delivery system but are then placed in a standard fashion. Pre-dilatation should be avoided to reduce the risk of migration, however if migration occurs the stents can be left to dissolve in the stomach. The stents are radiolucent but easily identified on CT with minimal artefact and thus might even aid with radiotherapy planning. Results: BD stents offer an exciting new strategy for therapy-resistant benign strictures as well as a supportive measure for oesophageal cancer undergoing non-surgical treatment. © 2009 European Society of Radiology.

AB - Background: We present our initial experience with a new biodegradable (BD) esophageal stent in two patients, one for a therapy-resistant benign esophageal stricture, and the other as a temporary measure during curative radiotherapy for oesophageal carcinoma. Methods: The BD stents need to be loaded into a conventional pull-back delivery system but are then placed in a standard fashion. Pre-dilatation should be avoided to reduce the risk of migration, however if migration occurs the stents can be left to dissolve in the stomach. The stents are radiolucent but easily identified on CT with minimal artefact and thus might even aid with radiotherapy planning. Results: BD stents offer an exciting new strategy for therapy-resistant benign strictures as well as a supportive measure for oesophageal cancer undergoing non-surgical treatment. © 2009 European Society of Radiology.

KW - Biodegradable

KW - Dilatation

KW - Endoscopy

KW - Oesophageal neoplasms

KW - Oesophageal stenosis

KW - Stents

U2 - 10.1007/s00330-009-1662-5

DO - 10.1007/s00330-009-1662-5

M3 - Article

C2 - 19921200

SN - 0938-7994

VL - 20

SP - 1069

EP - 1072

JO - European Radiology

JF - European Radiology

IS - 5

ER -

Woven polydioxanone biodegradable stents: A new treatment option for benign and malignant oesophageal strictures

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this